Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1934 1
1936 1
1945 1
1946 4
1947 9
1948 13
1949 7
1950 19
1951 26
1952 19
1953 12
1954 22
1955 16
1956 21
1957 14
1958 14
1959 14
1960 14
1961 19
1962 10
1963 17
1964 23
1965 20
1966 16
1967 21
1968 31
1969 31
1970 19
1971 34
1972 32
1973 35
1974 29
1975 35
1976 36
1977 48
1978 46
1979 34
1980 51
1981 51
1982 52
1983 56
1984 61
1985 60
1986 58
1987 77
1988 69
1989 70
1990 70
1991 65
1992 67
1993 73
1994 68
1995 85
1996 70
1997 60
1998 75
1999 73
2000 100
2001 73
2002 93
2003 127
2004 109
2005 111
2006 139
2007 155
2008 152
2009 164
2010 157
2011 201
2012 244
2013 214
2014 251
2015 270
2016 280
2017 310
2018 334
2019 350
2020 406
2021 437
2022 426
2023 356
2024 148

Text availability

Article attribute

Article type

Publication date

Search Results

7,053 results

Results by year

Filters applied: . Clear all
Page 1
ALK-positive lung cancer: a moving target.
Schneider JL, Lin JJ, Shaw AT. Schneider JL, et al. Nat Cancer. 2023 Mar;4(3):330-343. doi: 10.1038/s43018-023-00515-0. Epub 2023 Feb 16. Nat Cancer. 2023. PMID: 36797503 Free PMC article. Review.
Rapid adaptation to CDK2 inhibition exposes intrinsic cell-cycle plasticity.
Arora M, Moser J, Hoffman TE, Watts LP, Min M, Musteanu M, Rong Y, Ill CR, Nangia V, Schneider J, Sanclemente M, Lapek J, Nguyen L, Niessen S, Dann S, VanArsdale T, Barbacid M, Miller N, Spencer SL. Arora M, et al. Among authors: schneider j. Cell. 2023 Jun 8;186(12):2628-2643.e21. doi: 10.1016/j.cell.2023.05.013. Epub 2023 Jun 1. Cell. 2023. PMID: 37267950
Trends in the approval of cancer therapies by the FDA in the twenty-first century.
Scott EC, Baines AC, Gong Y, Moore R Jr, Pamuk GE, Saber H, Subedee A, Thompson MD, Xiao W, Pazdur R, Rao VA, Schneider J, Beaver JA. Scott EC, et al. Among authors: schneider j. Nat Rev Drug Discov. 2023 Aug;22(8):625-640. doi: 10.1038/s41573-023-00723-4. Epub 2023 Jun 21. Nat Rev Drug Discov. 2023. PMID: 37344568 Review.
Faecal metabolome and its determinants in inflammatory bowel disease.
Vich Vila A, Hu S, Andreu-Sánchez S, Collij V, Jansen BH, Augustijn HE, Bolte LA, Ruigrok RAAA, Abu-Ali G, Giallourakis C, Schneider J, Parkinson J, Al-Garawi A, Zhernakova A, Gacesa R, Fu J, Weersma RK. Vich Vila A, et al. Among authors: schneider j. Gut. 2023 Aug;72(8):1472-1485. doi: 10.1136/gutjnl-2022-328048. Epub 2023 Mar 23. Gut. 2023. PMID: 36958817 Free PMC article.
Zanubrutinib Versus Ibrutinib in Symptomatic Waldenström Macroglobulinemia: Final Analysis From the Randomized Phase III ASPEN Study.
Dimopoulos MA, Opat S, D'Sa S, Jurczak W, Lee HP, Cull G, Owen RG, Marlton P, Wahlin BE, Garcia-Sanz R, McCarthy H, Mulligan S, Tedeschi A, Castillo JJ, Czyz J, Fernández de Larrea C, Belada D, Libby E, Matous J, Motta M, Siddiqi T, Tani M, Trněný M, Minnema MC, Buske C, Leblond V, Treon SP, Trotman J, Chan WY, Schneider J, Allewelt H, Patel S, Cohen A, Tam CS. Dimopoulos MA, et al. Among authors: schneider j. J Clin Oncol. 2023 Nov 20;41(33):5099-5106. doi: 10.1200/JCO.22.02830. Epub 2023 Jul 21. J Clin Oncol. 2023. PMID: 37478390 Clinical Trial.
[COVID-19 Update].
Erber J, Schneider J, Kaiser R, Spinner CD. Erber J, et al. Among authors: schneider j. MMW Fortschr Med. 2023 Feb;165(2):58-61. doi: 10.1007/s15006-022-2232-x. MMW Fortschr Med. 2023. PMID: 36703066 Free PMC article. Review. German. No abstract available.
7,053 results